Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma

55Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Angiosarcoma of residual breast, arising after conservative surgery and radiotherapy for early breast cancer, is a rare tumor, with only 14 cases having so far been documented. The first was observed in 1987 and 7 of the 14 were reported in 1992 alone. Methods: Here, we present an additional case developing in residual breast 3.3 years after lumpectomy and radiotherapy. The other fourteen are reviewed. Results: Review of data from this series of patients reveals a higher incidence of breast oedema (67%) than that reported in the literature (4%). Another unusual finding is the shorter mean latency period (time interval from radiotherapy to onset of angiosarcoma) noted here (6 years) compared to the more than 10 years reported for other secondary angiosarcomas. Conclusions: In view of the widespread use of radiotherapy after breast-conserving surgery, and also its lack of benefit in terms of overall survival, every novel complication should be investigated. Given the apparent rise in incidence of this rare tumor over the last few years, doctors should be aware of the phenomenon in order to recognize and define it. © 1994 Kluwer Academic Publishers.

Cite

CITATION STYLE

APA

Del Mastro, L., Garrone, O., Guenzi, M., Cafiero, F., Nicolò, G., Rosso, R., & Venturini, M. (1994). Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma. Annals of Oncology, 5(2), 163–165. https://doi.org/10.1093/oxfordjournals.annonc.a058770

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free